Last reviewed · How we verify

Calcichew D3 — Competitive Intelligence Brief

Calcichew D3 (Calcichew D3) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mineral supplement / Vitamin supplement combination. Area: Bone health / Nutritional supplementation.

marketed Mineral supplement / Vitamin supplement combination Bone health / Nutritional supplementation Small molecule Live · refreshed every 30 min

Target snapshot

Calcichew D3 (Calcichew D3) — Takeda. Calcichew D3 provides supplemental calcium and vitamin D3 to maintain adequate serum calcium and phosphate levels and support bone health.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Calcichew D3 TARGET Calcichew D3 Takeda marketed Mineral supplement / Vitamin supplement combination
Calcium carbonate/vitamin D3 Calcium carbonate/vitamin D3 University of Alberta marketed Mineral supplement / Vitamin supplement combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mineral supplement / Vitamin supplement combination class)

  1. Takeda · 1 drug in this class
  2. University of Alberta · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Calcichew D3 — Competitive Intelligence Brief. https://druglandscape.com/ci/calcichew-d3. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: